Commerzbank Aktiengesellschaft FI Increases Holdings in Cigna Group $CI

Commerzbank Aktiengesellschaft FI increased its stake in Cigna Group (NYSE:CIFree Report) by 63.7% during the third quarter, Holdings Channel.com reports. The institutional investor owned 17,388 shares of the health services provider’s stock after buying an additional 6,764 shares during the period. Commerzbank Aktiengesellschaft FI’s holdings in Cigna Group were worth $5,013,000 as of its most recent filing with the SEC.

A number of other large investors have also added to or reduced their stakes in the stock. MBM Wealth Consultants LLC raised its holdings in shares of Cigna Group by 18.5% in the 3rd quarter. MBM Wealth Consultants LLC now owns 4,923 shares of the health services provider’s stock worth $1,419,000 after purchasing an additional 768 shares during the period. Oxbow Advisors LLC raised its stake in shares of Cigna Group by 2.1% in the third quarter. Oxbow Advisors LLC now owns 20,586 shares of the health services provider’s stock valued at $5,934,000 after buying an additional 433 shares during the period. Mn Services Vermogensbeheer B.V. grew its stake in shares of Cigna Group by 1.2% during the 3rd quarter. Mn Services Vermogensbeheer B.V. now owns 102,500 shares of the health services provider’s stock worth $29,546,000 after acquiring an additional 1,200 shares during the period. Deseret Mutual Benefit Administrators increased its holdings in Cigna Group by 52.3% in the 3rd quarter. Deseret Mutual Benefit Administrators now owns 1,378 shares of the health services provider’s stock worth $397,000 after acquiring an additional 473 shares during the last quarter. Finally, UniSuper Management Pty Ltd increased its holdings in Cigna Group by 34.0% in the 3rd quarter. UniSuper Management Pty Ltd now owns 25,798 shares of the health services provider’s stock worth $7,436,000 after acquiring an additional 6,546 shares during the last quarter. Hedge funds and other institutional investors own 86.99% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of research analysts recently weighed in on CI shares. Zacks Research upgraded shares of Cigna Group from a “strong sell” rating to a “hold” rating in a research note on Monday, January 5th. Deutsche Bank Aktiengesellschaft reduced their price target on Cigna Group from $415.00 to $301.00 and set a “buy” rating for the company in a research report on Monday, November 3rd. The Goldman Sachs Group dropped their price objective on Cigna Group from $370.00 to $330.00 and set a “buy” rating on the stock in a report on Tuesday, November 4th. Mizuho set a $325.00 target price on Cigna Group in a report on Friday, January 9th. Finally, Wolfe Research decreased their price target on Cigna Group from $345.00 to $325.00 and set an “outperform” rating on the stock in a research report on Wednesday, October 15th. One investment analyst has rated the stock with a Strong Buy rating, eighteen have given a Buy rating and four have issued a Hold rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average price target of $330.36.

Get Our Latest Research Report on Cigna Group

Insider Activity at Cigna Group

In other Cigna Group news, CEO David Cordani purchased 4,134 shares of the company’s stock in a transaction that occurred on Monday, November 3rd. The stock was bought at an average price of $241.88 per share, with a total value of $999,931.92. Following the completion of the purchase, the chief executive officer directly owned 157,935 shares of the company’s stock, valued at $38,201,317.80. The trade was a 2.69% increase in their position. The purchase was disclosed in a filing with the SEC, which is available at this hyperlink. 0.70% of the stock is currently owned by corporate insiders.

Cigna Group Stock Down 0.4%

Shares of NYSE:CI opened at $279.31 on Friday. The firm has a fifty day moving average of $274.46 and a 200 day moving average of $285.63. Cigna Group has a 52-week low of $239.51 and a 52-week high of $350.00. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.76 and a current ratio of 0.76. The firm has a market capitalization of $74.61 billion, a PE ratio of 12.32, a price-to-earnings-growth ratio of 0.98 and a beta of 0.26.

Cigna Group (NYSE:CIGet Free Report) last announced its quarterly earnings data on Thursday, October 30th. The health services provider reported $7.83 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $7.64 by $0.19. Cigna Group had a return on equity of 18.80% and a net margin of 2.29%.The firm had revenue of $69.57 billion for the quarter, compared to analysts’ expectations of $66.40 billion. During the same period last year, the firm earned $7.51 earnings per share. The company’s revenue for the quarter was up 9.5% compared to the same quarter last year. Cigna Group has set its FY 2025 guidance at 29.600- EPS. As a group, research analysts anticipate that Cigna Group will post 29.77 EPS for the current fiscal year.

About Cigna Group

(Free Report)

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.

Recommended Stories

Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cigna Group (NYSE:CIFree Report).

Institutional Ownership by Quarter for Cigna Group (NYSE:CI)

Receive News & Ratings for Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.